Humanized in vitro and in vivo Models in Drug Discovery and Development
Sunday April 22, 2018
9:30 am
-
12:00 pm
Eastern Time (ET)
Room 15B
CVP
DDD
DMDD
TOX
Chair :
Aarti Sawant-Basak
Pfizer Inc.
Xinxin Ding
University of Arizona
Increasingly sophisticated, powerful in vitro and in vivo models are being developed for drug discovery and development, which are complex to understand or master for the average users. Thus, the objective of this symposium is to bring experts on the generation and utility of such in vitro and in vivo models together to present the latest developments, discuss potential pitfalls and challenges, and showcase successful applications of the models in drug discovery and development research, driving appreciation for novel approaches and perhaps new collaborations.
Speakers
Shyam Sundhar Bale
- Draper Laboratories
Capturing Liver Function In Vitro: Micro-engineered Biomimetic Liver Platforms for Drug Metabolism and Inter-organ Interactions
Murat Cirit
- MIT – Translational Center of Tissue Chip Technologies
Quantitative DMPK Applications of Microphysiological Systems
Karl-Dimiter Bissig
- Baylor College of Medicine
Human Liver Chimeric Mice to Predict Human Drug Metabolism and Toxicity: The Chances and Challenges
Shujuan Chen
- University of California, San Diego
Glucuronidation in Humanized and Conditional Knockout Animal Models
Piyush Bajaj
- Takeda Pharmaceuticals
Industrial Perspectives of Microphysiological Systems in Drug Discovery and Development